Neumora Therapeutics

NMRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$146.277 M

$0.78 +12.53%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

$236.9M

#932 by earnings

Shares outstanding

187,895,912

Latest filing cover page

P/E ratio

0.6

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#106Armata PharmaceuticalsARMP$156.2M
#107Tenaya TherapeuticsTNYA$153.0M
#108Neumora TherapeuticsNMRA$146.3M
#109Caribou BiosciencesCRBU$143.7M
#110enGene TherapeuticsENGN$137.4M

What if Neumora Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$160,908.08

Per share 206,690× higher

Bitcoin $1.74T

$9,269.25

Per share 11,907× higher

Nvidia $5.52T

$29,355.44

Per share 37,708× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Neumora Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.